Breaking News, Promotions & Moves

Gannet BioChem Fills Key Executive Leadership Positions

Names Nicholas Shackley as CEO; Chris Edwards as CFO; and Dr. Tony Sander as COO.

Author Image

By: Charlie Sternberg

Associate Editor

Nicholas Shackley, CEO.

Gannet BioChem, a specialty chemical Contract Development and Manufacturing Organization (CDMO), has appointed several key executives following its recent acquisition by Ampersand Capital Partners. The new leadership team includes: Nicholas Shackley as Chief Executive Officer Chris Edwards as Chief Financial Officer Dr. Tony Sander as Chief Operating Officer “These leadership appointments mark an exciting new chapter for Gannet BioChem as an independent company,” sai...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters